# Transcriptomic Profile of Oral Cancer Lesions: A Proof-of-Concept Pilot Study of FFPE Tissue Sections

**Authors:** Madison E. Richards, Micaela F. Beckman, Ernesto Martinez Duarte, Joel J. Napenas, Michael T. Brennan, Farah Bahrani Mougeot, Jean-Luc C. Mougeot

PMC · DOI: 10.3390/ijms26136263 · International Journal of Molecular Sciences · 2025-06-28

## TL;DR

This study uses preserved tissue samples to compare gene activity in oral cancer and breast cancer, identifying unique gene patterns in oral cancer.

## Contribution

The study demonstrates the feasibility of using FFPE samples to identify OSCC-specific transcriptomic profiles and potential biomarkers.

## Key findings

- OSCC and BC FFPE samples showed distinct clustering in PCA and had 9194 differentially expressed genes.
- Downregulated KEGG pathways in OSCC included leukocyte and apoptosis-related processes, while upregulated genes involved PIK3 and NF-kappaB signaling.
- KRT-family genes and periodontal pathogens were suggested as potential contributors to the progression from OPMD to OSCC.

## Abstract

Oral squamous cell carcinoma (OSCC) is a malignancy that affects the oral mucosa and is characterized by indurated oral lesions. The RNAseq of formalin-fixed, paraffin-embedded (FFPE) samples is readily available in clinical settings. Such samples have long-term preservation and can provide highly accurate transcriptomic information regarding gene fusions, isoforms, and allele-specific expression. We determined differentially expressed genes using the transcriptomic profiles of oral potentially malignant disorder (OPMD) FFPE oral lesion samples of patients who developed OSCC over years. A technical comparison was completed comparing breast cancer (BC) FFPE publicly available data in this proof-of-concept pilot study. OSCC FFPE samples were collected from patients (N = 3) who developed OSCC 3 to 5 years following OPMD diagnosis (n = 3) and were analyzed using RNAseq. RNAseq sequences from the FFPE OSCC samples and publicly available FFPE samples of BC patients (n = 6) (Gene Expression Omnibus Database, GSE58135) aligned to human reference (GRCh38.p13). Genes were counted using the Spliced Transcripts Alignment to a Reference (STARv2.7.9a) software. Differential expression was determined in R using DESeq2v1.40.2 comparing OSCC to BC samples. Principal component analysis (PCA) plots were completed. Differential Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways were determined via the Pathviewv.1.40.0 program. STRING v12.0 was used to determine protein–protein interactions between genes represented in more than one KEGG pathway. STARv2.7.9a identified 27,237 and 30,343 genes among the OSCC and BC groups, respectively. DESeq2v1.40.2 determined 9194 differentially expressed genes (DEPs), 4466 being upregulated (OSCC > BC) and 4728 being downregulated (BC > OSCC) (padj < 0.05). Most significant genes included KRT6B, SERPINB5, and DSC3 (5- to 10-fold change range; padj < 10 × 10−100). PCA showed that BC and OSCC samples clustered as separate groups. Pathviewv.1.40.0 identified 17 downregulated KEGG pathways in OSCC compared to the BC group. No upregulated KEGG pathways were identified. STRINGv12.0 determined Gene Ontology Biological Process enrichments for leukocytes and apoptosis in upregulated KEGG genes including multiple PIK3 genes and NIK/NF-kappaB signaling and metabolic responses from lipopolysaccharides in downregulated KEGG genes including CHUK and NFKB1. Using FFPE samples, we determined DEPs characteristic of OSCC and distinct from BC. KRT-family genes and lipopolysaccharide producing periodontal pathogens may be further investigated for their involvement in the OPMD to OSCC transition.

## Linked entities

- **Genes:** KRT6B (keratin 6B) [NCBI Gene 3854], SERPINB5 (serpin family B member 5) [NCBI Gene 5268], DSC3 (desmocollin 3) [NCBI Gene 1825], PIK3CG (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma) [NCBI Gene 5294], CHUK (component of inhibitor of nuclear factor kappa B kinase complex) [NCBI Gene 1147], NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790], MAP3K14 (mitogen-activated protein kinase kinase kinase 14) [NCBI Gene 9020]
- **Diseases:** oral squamous cell carcinoma (MONDO:0004958), breast cancer (MONDO:0004989)

## Full-text entities

- **Genes:** KRT6B (keratin 6B) [NCBI Gene 3854] {aka CK-6B, CK6B, K6B, KRTL1, PC2, PC4}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, CHUK (component of inhibitor of nuclear factor kappa B kinase complex) [NCBI Gene 1147] {aka BPS2, IKBKA, IKK-1, IKK-alpha, IKK1, IKKA}, DSC3 (desmocollin 3) [NCBI Gene 1825] {aka CDHF3, DSC, DSC1, DSC2, DSC4, HT-CP}, SERPINB5 (serpin family B member 5) [NCBI Gene 5268] {aka PI5, maspin}, MAP3K14 (mitogen-activated protein kinase kinase kinase 14) [NCBI Gene 9020] {aka FTDCR1B, HS, HSNIK, IMD112, NIK}, PIK3CG (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma) [NCBI Gene 5294] {aka IMD97, PI3CG, PI3K, PI3Kgamma, PIK3, p110gamma}
- **Diseases:** Oral Cancer Lesions (MESH:D009062), malignancy (MESH:D009369), OPMD (MESH:C537245), BC (MESH:D001943), OSCC (MESH:D000077195), indurated oral lesions (MESH:D009059)
- **Chemicals:** formalin (MESH:D005557), lipopolysaccharide (MESH:D008070), paraffin (MESH:D010232)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12250292/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12250292/full.md

## References

47 references — full list in the complete paper: https://tomesphere.com/paper/PMC12250292/full.md

---
Source: https://tomesphere.com/paper/PMC12250292